Was reading through the recent Wise owl update on analytica (ALT) and noted the below piece. MLA has been for awhile signed up to distribute their burette product throughout australia. Thought it was interesting as it states delays due to manufacturing enhancements, so I wouldn't think this 500k revenue has been included in MLA's reports. Worth keeping an eye on how the autoburette progresses as has reasonable potential to drive further gains in MLA's non-medivet revenue.
"Commercial trials have been implemented with three major Australian medical institutions - the New South Wales (NSW) Ambulance Service, Concord Repatriation Hospital, and an undisclosed hospital in Queensland. Concord Repatriation Hospital has subsequently entered a supply agreement expected to be worth $0.5m pa, although recent engineering and manufacturing enhancements have delayed its execution."
MLA Price at posting:
14.5¢ Sentiment: LT Buy Disclosure: Held
